Trial Profile
Clinical Trials Insight: 700053725
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use